We have made use of RNARNA in situ hybridization to study the presence of cells producing mRNA for interleukin 4 (IL-4) in the developing thymus, spleen, and
Recently, complementary DNA for the gene encoding the glycoprotein interleukin 4 (IL-4) was isolated (1) . IL-4, previously called B cell-stimulatory factor 1 (2) or B-cell differentiation factor for IgGi (3) , is now known to possess several biological activities. Thus, recombinant and highly purified induces activated B lymphocytes to switch from IgM to IgG1 and IgE (1, (4) (5) (6) , increases the level of Ia molecules on the cell membrane of resting B lymphocytes (1, 2, 7) , supports proliferation of some interleukin 2 (IL-2)-dependent cell lines (8) (9) (10) as well as of mast cell lines (8, 9) , promotes growth of early lymphoid precursors from bone marrow (11) , and induces both growth and differentiation of normal intrathymic T-cell precursors from fetal mice in vitro (12) .
Although receptors specific for IL-4 on different types of target cells have been demonstrated (13, 14) , the mechanism(s) by which IL-4 exerts its broad spectrum of activities is still unknown. Likewise, the frequency, tissue distribution, and ontogeny of the cells capable of producing are not known. All of the information available concerning the production of IL-4 comes from studies performed with tumor T-cell lines (15) , with T-cell hybrids (3) and, recently, with antigen-specific T-cell clones that were selected for their capacity to produce IL-4 (16) . The latter clones possess a phenotype of helper T cells-i.e, they are Thy-1+, L3T4', Lyt-2-, and express the receptor for IL-2 (P.S., unpublished results)-and have been proving useful for the isolation of cDNAs encoding IL-4 (1) and other lymphokines (17) .
Both the interference of unrelated cytokines in the assay systems used to detect IL-4 activity and the outgrowth of unrelated cells have made any attempt to determine the frequency of IL-4-secreting cells in normal tissues unsuccessful. Therefore, we opted for using RNA-RNA in situ hybridization to study the presence of cells expressing mRNA for IL-4 in the developing thymus and in peripheral lymphoid organs from adult mice. Here Separation of Cells. Spleen cell suspensions were prepared by standard procedures (5, 16) . Thymocyte cell suspensions from fetal mice (days 14-18 of gestation) were prepared as described (18) . The T-cell line 2.19 has been described and was maintained in culture as detailed elsewhere (16 C57BL/6 or BALB/c mice at 370C for 72 hr. The cells from the different cultures were harvested, the dead cells were removed by centrifugation over density gradients (Lymphopred), and the viable cells were used for cytocentrifuge preparations. Fetal thymocytes (2.0 x 106 cells per ml of culture medium) were stimulated with PMA (10 ng/ml) and ionomycin (500 ng/ml) at 370C for 4-6 hr. The cells were harvested, washed, and used for cytocentrifuge preparations.
Cytocentrifuge Preparations. Glass slides were immersed in 70% ethanol and air-dried. The cells suspended in balanced salt solution containing 10%o fetal calf serum were loaded on glass slides (105 cells per slide) with the aid of a cytocentrifuge. The cell smears were fixed in paraformaldehyde (4% diluted in phosphate-buffered saline) for 1 min, were transferred into a solution of 70% ethanol, and subsequently were stored at +40C until used.
Preparation of the IL4 Probe. The Rsa I-Rsa I fragment from the cDNA clone pSP6KmIL4-293 (1), containing all of the coding sequence for IL-4, was subcloned into the gemini SP6/T7 vectors. The pUC18 vector containing the Rsa I-Rsa I fragment was kindly provided by T. Honjo (Kyoto University, Kyoto, Japan). Linearized plasmids were used as templates for the synthesis in vitro of radioactive RNA probes complementary to the cellular IL-4 mRNA. RNA was also transcribed from the opposite direction (sense) and used as a negative control. Approximately 2 x 108 cpm were incorporated into RNA per tug of RNA template. The size of the full-length probe mRNA was =400 nucleotides. Nonradioactive RNA was also synthesized in the sense orientation and used to compete with the binding of the radioactive probes to the cellular mRNA.
-.
In Situ Hybridization. Fixed slides prepared as described above were rinsed twice in 2x SSC (2x SSC = 0.3 M NaCI/0.03 M sodium citrate) and then acetylated at pH 8 with 0.25% acetic anhydride for 10 min. After this, the slides were rinsed in 2 x SSC and phosphate-buffered saline and were immersed in 0. 
RESULTS AND DISCUSSION
The T-cell line 2.19, known to produce IL-4 (5, 16) and the original source from which cDNA for the gene encoding IL-4 was isolated (1), was initially used to optimize the conditions for the detection of mRNA for IL-4 by in situ hybridization. Next, we checked the specificity of the in situ RNARNA hybridization procedure by incubating cytocentrifuge preparations of 6-hr Con A-stimulated 2.19 T cells with RNA probes in the sense orientation (i.e., same polarity as the cellular mRNA) and by hybridizing RNase-treated cytocentrifuge preparations of 2.19 cells with RNA probes in the antisense orientation (i.e., complementary to cellular mRNA). The results show that no hybridization could be observed with either the probe in the wrong orientation (Fig. 1D) or when the slides were pretreated with RNase (Fig. 1C) . Furthermore, cold in vitro synthesized IL-4 mRNA in the sense orientation, included during the hybridization procedure, inhibited the binding of the complementary mRNA probe to the cellular IL-4 mRNA (not shown).
We also studied the effect of cyclosporin A, a drug known to inhibit the transcription of genes coding for the growth factors IL-2 and interleukin 3 (IL-3) (19) Having defined the conditions and checked the specificity of the in situ hybridization procedure, we next studied the presence of cells in the spleen from several mouse strains expressing IL-4 mRNA following their stimulation either by the polyclonal T-cell activator Con A or by alloantigens. The results (Table 2) show that about 1 of 300-400 spleen cells stimulated by Con A for 48 hr expressed IL-4 mRNA as assessed by in situ RNA-RNA hybridization. Spleen cells expressing IL-4 mRNA after activation by alloantigens were clearly observed, but at much lower frequency than that found in Con A-stimulated spleen cells ( (Table 2) . It is worth noting that even at the peak of the response, the frequency of spleen cells expressing IL-4 mRNA was not higher than 1 in =300 viable cells and that the actual increase in the number of cells producing IL-4 mRNA was not marked (i.e., between 12 and 48 hr after activation, the number of cells producing IL-4 mRNA only increased 2-fold). These findings may indicate the capacity of nonblastoid spleen cells to synthesize high levels of mRNA for IL-4 (in Table 2 , see the column designated "% blasts") and the limited proliferative activity of the cell populations expressing IL-4 mRNA following their activation by Con A.
We recently have described that recombinant IL-4 promotes the growth of about one of four intrathymic T-cell precursors from fetal mice (days 14-15 of gestation) (12) . It was considered important to determine whether fetal thymocytes can express mRNA for IL-4. Thus, fetal thymocytes at various ages of gestation (days 14, 15, 16, 17, and 18) were stimulated with the combination of PMA and the calcium ionophore ionomycin for 4-6 hr, and the presence of cells expressing IL-4 mRNA was assessed by in situ RNA-RNA (Table 3) . Remarkably, fetal thymocytes at day 14 ofgestation contained both the highest number of cells producing IL-4 mRNA and the cells expressing the highest levels of mRNA for IL-4 ( Table 3 ). The frequency of fetal thymocytes expressing IL-4 mRNA sharply decreased at day 16 of gestation, and very few IL-4 mRNA-producing cells were observed in 18-day fetal thymocytes ( Table 3 ). The data show that 1 ofabout 10 fetal thymocytes at day 14 ofgestation can express mRNA for IL-4 after their activation by PMA/ ionomycin and that the number offetal thymocytes with such potential decreases as they differentiate within the thymus. The present results provide strong support for the proposition that IL-4 may play an essential role in the early stages of T-cell development within the thymus, promoting growth and differentiation of the T-cell progenitors (12) .
In summary, by using in situ RNARNA hybridization for the detection at the single-cell level of expression of IL-4 mRNA, we have provided here evidence that: (i0 about 1 of =300 spleen cells may express mRNA for IL-4 after stimulation by Con A; (ii) that cyclosporin A inhibits the expression of IL-4 mRNA by the T-cell line 2.19 induced by Con A; and (iii) that about 1 of 10 fetal thymocytes at day 14 of gestation expresses IL-4 mRNA after proper stimulation in vitro and that both the number of fetal thymocytes and the 
